Literature DB >> 24763813

The unforeseen toll of birth defects and their economic burden at a tertiary care public institute in Mumbai.

Mamta Muranjan1, P Vijayalakshmi.   

Abstract

OBJECTIVES: To determine the proportion of patients with birth defects receiving indoor medical care and the economic burden incurred by the Institution in terms of cost of hospitalization.
METHODS: This single center, prospective, observational study recruited children>28 d and <12 y of age with birth defect(s) not attributable to an acquired disease. Demographic data, maternal and antenatal data, nature of the defect and information about current and past hospitalization were recorded. Economic burden was estimated by computing bed charges and daily costs incurred by the Institution.
RESULTS: Ninety-eight children (mean age was 3.18 y, M : F ratio was 2.4:1) with 268 birth defects represented 13% of indoor admissions. The cardiovascular system was involved in 42.9%. The defect was isolated in 58.2% of cases and 41.8% (9.2% having Down syndrome) had multiple defects. Mean duration of hospital stay (11.23 d) of the birth defect cohort was significantly more (p value=0.0005) than other children (7.81 d). Average cost of stay for those with birth defects (18.3% of the total cost) and other indoor patients was INR 23,481 and INR 16,328 respectively.
CONCLUSIONS: Birth defects are an emerging burden in referral centers, incurring one-fifth of the hospital expenditure, partly due to increased length of stay. The figure is an underestimate as the expenses are highly subsidized in a Public health facility.

Entities:  

Mesh:

Year:  2014        PMID: 24763813     DOI: 10.1007/s12098-014-1363-1

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  9 in total

1.  Methodological issues in setting up a surveillance system for birth defects in India.

Authors:  Seshadri Suresh; Gurusamy Thangavel; Jagadeesh Sujatha; Suresh Indrani
Journal:  Natl Med J India       Date:  2005 Sep-Oct       Impact factor: 0.537

2.  Reduced costs of congenital anomalies from fetal ultrasound: are they sufficient to justify routine screening in the United States?

Authors:  N J Waitzman; P S Romano
Journal:  Ann N Y Acad Sci       Date:  1998-06-18       Impact factor: 5.691

3.  Burden of genetic disorders in India.

Authors:  I C Verma
Journal:  Indian J Pediatr       Date:  2000-12       Impact factor: 1.967

Review 4.  Burden, differentials, and causes of child deaths in India.

Authors:  Chandrakant Lahariya; Vinod K Paul
Journal:  Indian J Pediatr       Date:  2010-09-10       Impact factor: 1.967

5.  Hospital stays, hospital charges, and in-hospital deaths among infants with selected birth defects--United States, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-01-19       Impact factor: 17.586

6.  The burden of genetic disease on inpatient care in a children's hospital.

Authors:  Shawn E McCandless; Jeanne W Brunger; Suzanne B Cassidy
Journal:  Am J Hum Genet       Date:  2003-12-12       Impact factor: 11.025

7.  Preliminary study into the economic burden of Down syndrome in China.

Authors:  Yingyao Chen; Xu Qian; Jie Zhang; Jun Li; Annie Chu; Stuart O Schweitzer
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2008-01

8.  Estimates of the economic costs of birth defects.

Authors:  N J Waitzman; P S Romano; R M Scheffler
Journal:  Inquiry       Date:  1994       Impact factor: 1.730

9.  A retrospective population-based study of childhood hospital admissions with record linkage to a birth defects registry.

Authors:  Lyn Colvin; Carol Bower
Journal:  BMC Pediatr       Date:  2009-05-10       Impact factor: 2.125

  9 in total
  1 in total

1.  EUROlinkCAT protocol for a European population-based data linkage study investigating the survival, morbidity and education of children with congenital anomalies.

Authors:  Joan K Morris; Ester Garne; Maria Loane; Ingeborg Barisic; James Densem; Anna Latos-Bieleńska; Amanda Neville; Anna Pierini; Judith Rankin; Anke Rissmann; Hermien de Walle; Joachim Tan; Joanne Emma Given; Hugh Claridge
Journal:  BMJ Open       Date:  2021-06-28       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.